To appraise the clinical and cost effectiveness of dexamethasone intracanalicular insert within its marketing authorisation for treating inflammation and pain after cataract surgery.
Status Awaiting development
Decision None selected
Process TA
ID number 1154

Project Team

Project lead Michelle Adhemar

Email enquiries


Key events during the development of the guidance:

Date Update
11 September 2017 (00:00) Scoping workshop
18 July 2017 - 15 August 2017 Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators

For further information on our processes and methods, please see our CHTE processes and methods manual